Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

The prospects of glycan biomarkers for the diagnosis of diseases

The prospects of glycan biomarkers for the diagnosis of diseases Over 40 years of literature shows that glycosylation is greatly affected by diseases such as cancer. This opinion article argues the intrinsic advantages of using glycans as disease markers over other biomolecules and the potential of glycan profiling for diagnosing and determining the progression of disease. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Molecular BioSystems Royal Society of Chemistry

The prospects of glycan biomarkers for the diagnosis of diseases

Loading next page...
 
/lp/royal-society-of-chemistry/the-prospects-of-glycan-biomarkers-for-the-diagnosis-of-diseases-JCj9vkE01H

References (23)

Publisher
Royal Society of Chemistry
Copyright
This journal is © The Royal Society of Chemistry
ISSN
1742-206X
eISSN
1742-2051
DOI
10.1039/b811781k
pmid
19081926
Publisher site
See Article on Publisher Site

Abstract

Over 40 years of literature shows that glycosylation is greatly affected by diseases such as cancer. This opinion article argues the intrinsic advantages of using glycans as disease markers over other biomolecules and the potential of glycan profiling for diagnosing and determining the progression of disease.

Journal

Molecular BioSystemsRoyal Society of Chemistry

Published: Nov 6, 2008

There are no references for this article.